Works matching Acute respiratory distress syndrome (ARDS)


Results: 5000
    1
    2
    3

    Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.

    Published in:
    Intensive Care Medicine, 2022, v. 48, n. 1, p. 36, doi. 10.1007/s00134-021-06570-4
    By:
    • Bellingan, G.;
    • Jacono, F.;
    • Bannard-Smith, J.;
    • Brealey, D.;
    • Meyer, N.;
    • Thickett, D.;
    • Young, D.;
    • Bentley, A.;
    • McVerry, B. J.;
    • Wunderink, R. G.;
    • Doerschug, K. C.;
    • Summers, C.;
    • Rojas, M.;
    • Ting, A.;
    • Jenkins, E. D.
    Publication type:
    Article
    4
    6
    7
    8

    Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.

    Published in:
    Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02953-6
    By:
    • Aghayan, Hamid Reza;
    • Salimian, Fatemeh;
    • Abedini, Atefeh;
    • Fattah Ghazi, Samrand;
    • Yunesian, Masud;
    • Alavi-Moghadam, Sepideh;
    • Makarem, Jalil;
    • Majidzadeh-A, Keivan;
    • Hatamkhani, Ali;
    • Moghri, Maryam;
    • Danesh, Abbas;
    • Haddad-Marandi, Mohammad Reza;
    • Sanati, Hassan;
    • Abbasvandi, Fereshteh;
    • Arjmand, Babak;
    • Azimi, Pourya;
    • Ghavamzadeh, Ardeshir;
    • Sarrami-Forooshani, Ramin
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Impact of the Angiotensin-Converting Enzyme (ACE) Inhibitors on the Course of the Acute Respiratory Distress Syndrome (ARDS) Developed During COVID-19 and Other Severe Respiratory Infections Under Hyperferritinemia Conditions: A Cohort Study.

    Published in:
    Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2023, p. 1, doi. 10.1177/11795484231180391
    By:
    • Rurua, Magda;
    • Pachkoria, Elena;
    • Sanikidze, Tamar;
    • Machvariani, K;
    • Ormocadze, George;
    • Jomidava, Tinatin;
    • Dzidziguri, Diana;
    • Ratiani, Levan
    Publication type:
    Article
    27

    Impact of the Angiotensin-Converting Enzyme (ACE) Inhibitors on the Course of the Acute Respiratory Distress Syndrome (ARDS) Developed During COVID-19 and Other Severe Respiratory Infections Under Hyperferritinemia Conditions: A Cohort Study.

    Published in:
    Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2023, v. 17, p. 1, doi. 10.1177/11795484231180391
    By:
    • Rurua, Magda;
    • Pachkoria, Elena;
    • Sanikidze, Tamar;
    • Machvariani, K;
    • Ormocadze, George;
    • Jomidava, Tinatin;
    • Dzidziguri, Diana;
    • Ratiani, Levan
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    When Acute Respiratory Distress Syndrome is not ARDS.

    Published in:
    Lung (0341-2040), 2016, v. 194, n. 5, p. 865, doi. 10.1007/s00408-016-9917-9
    By:
    • Tonelli, Roberto;
    • Andreani, Alessandro;
    • Castaniere, Ivana;
    • Fantini, Riccardo;
    • Mengoli, Cecilia;
    • Rossi, Giulio;
    • Marchioni, Alessandro
    Publication type:
    Article
    45
    46
    47
    48
    49
    50